Companies: 10,795·Total market cap: $144.5T
Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc.

MNMDNASDAQHealthcare
$20.69
+$0.09(+0.44%)
Market Cap$1.6B
P/E Ratio—
52W High$21.08
52W Low$4.7
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Mind Medicine (MindMed) Inc. (MNMD) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MNMD · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.50mnmd eps ttm · mnmd earnings per shareEarnings history
PE Ratio (TTM)—mnmd pe ratio ttm · mnmd price to earningsPE Ratio deep dive
Revenue (TTM)0.00mnmd revenue ttm · mnmd annual revenueFull revenue history
Dividend YieldNo Dividenddoes mnmd pay dividends · mnmd dividend yieldDividend history
Shares Outstanding89.3Mmnmd shares outstanding · mnmd floatShares outstanding history
Next EarningsTBAmnmd earnings date · mnmd next earningsEarnings history

Explore Mind Medicine (MindMed) Inc. Data

mnmd stock data · financials
Market Cap$1.6Bmnmd market cap · mnmd valuation
Analyst Forecast$20 · Buy
DividendsNo Dividenddoes mind medicine (mindmed) inc. pay dividends · mnmd dividend yield
Revenue—mind medicine (mindmed) inc. annual revenue · mnmd revenue
EarningsEPS $-2.06-33.77%mnmd earnings · mnmd eps
PE Ratio—mnmd pe ratio · mnmd price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
mind medicine (mindmed) inc. revenue · mnmd revenue 2025
FY 2025Net Income-$183.8M▼ 69.12% YoY
202320242025
mind medicine (mindmed) inc. net income · mnmd profit 2025
FY 2025EPS$-2.06▼ 33.77% YoY
202320242025
mnmd eps · mind medicine (mindmed) inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$237.5MEPS: $-2.50View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis mnmd a buy · mnmd analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$14.00Low
$20.69Current
$20.00Avg Target3.33% downside
$28.00High
mnmd price target · mnmd 12 month forecast

Total: 1 · Buy rate: 100.0%

The MNMD analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $20.00, representing -3.33% downside from the current price of $20.69.

Stock Performance

Full History
1D-5.44%
1W-8.04%
1M+0.05%
3M+13.49%
YTD+54.52%
1Y+198.56%
5Y-56.76%

About Mind Medicine (MindMed) Inc.

CEORobert Barrow
IPO DateNov 15, 2016
Employees74
CountryCA
Websitemindmed.co

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering new treatments for various brain health conditions, encompassing psychiatric disorders, addiction, pain,…

BiotechnologyHealthcareNASDAQCA

what is mind medicine (mindmed) inc. · mnmd stock overview · mind medicine (mindmed) inc. company profile · who is mind medicine (mindmed) inc. ceo · mnmd NASDAQ · mind medicine (mindmed) inc. headquarters · mind medicine (mindmed) inc. business segments

About Stock Overview & Key Data

Mind Medicine (MindMed) Inc. (MNMD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 15, 2016. As of the latest trading session, MNMD stock price is $20.69, with a market capitalization of $1.6B. The stock has returned +198.56% over the past 12 months and +54.52% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Mind Medicine (MindMed) Inc. stock is Buy, with an average 12-month price target of $20.00. In fiscal year 2025, Mind Medicine (MindMed) Inc. reported revenue of — and net income of -$183.8M. For detailed data — including Mind Medicine (MindMed) Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Mind Medicine (MindMed) Inc. (MNMD) stock price is $20.69. The stock is traded on NASDAQ under the ticker symbol MNMD. The 52-week range is $4.70 – $21.08.

MNMD stock priceMNMD quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice